Skip to main content
logo
Genscript Biotech Corporation (HKG:1548)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.06
-0.48 (-3.30%)
May 15, 2026, 4:09 PM HKT

Genscript Biotech Revenue

In the year 2025, Genscript Biotech had annual revenue of $959.53M USD with 61.40% growth. Genscript Biotech had revenue of $440.75M in the half year ending December 31, 2025.

Revenue
$959.53M
Revenue Growth
+61.40%
P/S Ratio
4.12
Revenue / Employee
$155.64K
Employees
6,165
Market Cap
30.76B HKD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025959.53M365.04M61.40%
Dec 31, 2024594.49M34.01M6.07%
Dec 31, 2023560.48M-65.22M-10.42%
Dec 31, 2022625.70M135.60M27.67%
Dec 31, 2021490.10M99.25M25.39%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
3SBio19.69B
Shanghai Henlius Biotech7.42B
RemeGen3.84B
Shanghai Junshi Biosciences3.10B
InnoCare Pharma2.87B
Duality Biotherapeutics2.06B
Biocytogen Pharmaceuticals (Beijing)1.78B
Keymed Biosciences797.12M
Revenue Rankings

Genscript Biotech News

More News